<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-26T23:15:55+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>“GIST 新时空”专栏 |张鹏副教授公开课：2020 CTOS胃肠间质瘤研究进展</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/d208PAE-LNXTtLpjw29G8w</id>
    <link href="https://mp.weixin.qq.com/s/d208PAE-LNXTtLpjw29G8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>六聚钱江弦歌不辍，精准诊疗再续篇章</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/Sf6WcShq0Xh0iz2B_N0Q3g</id>
    <link href="https://mp.weixin.qq.com/s/Sf6WcShq0Xh0iz2B_N0Q3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博学慎思，明辨笃行——2020年CACA肺癌靶向治疗专家研讨会郑州站</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/Xy2O--Km8lI8Z1SL3TOKHg</id>
    <link href="https://mp.weixin.qq.com/s/Xy2O--Km8lI8Z1SL3TOKHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刘莉教授：从临床研究到真实世界研究，深入探讨纳武利尤单抗在晚期NSCLC二线和后线治疗中的临床价值</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/NmY7cmXnBbenP7iz24JNvw</id>
    <link href="https://mp.weixin.qq.com/s/NmY7cmXnBbenP7iz24JNvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ESMO Asia 2020丨高庆蕾教授：打造“女娲”平台， 推动中国真实世界研究与优质患者管理</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/eACZ31IUDfOePLwaT5ifYw</id>
    <link href="https://mp.weixin.qq.com/s/eACZ31IUDfOePLwaT5ifYw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【乳此可奈】李俊杰教授：HER2阳性早期乳腺癌新辅助治疗后non-pCR患者强化辅助治疗探索</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/ThnJ6IYK_ipoZat0Xt7eeQ</id>
    <link href="https://mp.weixin.qq.com/s/ThnJ6IYK_ipoZat0Xt7eeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NCCN乳腺癌指南又上新啦！</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/esafrCWelLjeTmcjhFHrpA</id>
    <link href="https://mp.weixin.qq.com/s/esafrCWelLjeTmcjhFHrpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【会议预告】领创新、拓氏界——研究型医院能力提升系列会议首场来袭，11月29日邀您一睹晚期乳腺癌临床试验专场的芳容</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/wYPv82xHgz8asNxRJ98jHQ</id>
    <link href="https://mp.weixin.qq.com/s/wYPv82xHgz8asNxRJ98jHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>对话大咖 | 张力教授：贝美纳（恩沙替尼）获批上市，填补ALK-TKI国产空白！</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/XiYALtHjtCOBwehEUuEOGQ</id>
    <link href="https://mp.weixin.qq.com/s/XiYALtHjtCOBwehEUuEOGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《上皮性卵巢癌PARP抑制剂生物标志物检测中国专家共识》发布，吴小华教授解其中要义</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/m5L01024gfPsT0ArXoAfGg</id>
    <link href="https://mp.weixin.qq.com/s/m5L01024gfPsT0ArXoAfGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020CCO】陈功教授专访：直肠癌治疗新趋势，更加重视功能保全</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/1Q0HCV4Xjbe-6vPUcQjvXA</id>
    <link href="https://mp.weixin.qq.com/s/1Q0HCV4Xjbe-6vPUcQjvXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首届深莞惠消化道肿瘤高峰论坛暨深圳市消化道肿瘤MDT培训班圆满落幕</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/v2gNNv1vWRtqVnIKgpyO2Q</id>
    <link href="https://mp.weixin.qq.com/s/v2gNNv1vWRtqVnIKgpyO2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【悦谈 Vol.1】食管癌文献月评|食管癌二线免疫治疗获突破，围手术期治疗方案再优化</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/W_GYHMW_yZcuHcMirpdMSA</id>
    <link href="https://mp.weixin.qq.com/s/W_GYHMW_yZcuHcMirpdMSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【11月26日】中国消化道肿瘤免疫治疗学术论坛-2020 POST ESMO第十四场</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/q1NhGiO9U5kw_5epxbuyrQ</id>
    <link href="https://mp.weixin.qq.com/s/q1NhGiO9U5kw_5epxbuyrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CCO 2020】马骏教授：鼻咽癌治疗中国经验改变国际指南，未来仍需探索</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/KyU3rwy5Cd8w_PXVSxYlzg</id>
    <link href="https://mp.weixin.qq.com/s/KyU3rwy5Cd8w_PXVSxYlzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO ASIA︱恩沃利单抗治疗MSI-H/dMMR晚期实体瘤展现非凡实力</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/WoutsyrD-VrXE_OAvJUbSQ</id>
    <link href="https://mp.weixin.qq.com/s/WoutsyrD-VrXE_OAvJUbSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CCO 2020】吴小华教授：子宫内膜癌分子分型逐渐走向临床</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/uK4PmLXFxrMU977c6TxyNA</id>
    <link href="https://mp.weixin.qq.com/s/uK4PmLXFxrMU977c6TxyNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>梁寒教授：GIST精准治疗前沿进展与展望</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/eaobh-0rI9RaTqx_tfBAZw</id>
    <link href="https://mp.weixin.qq.com/s/eaobh-0rI9RaTqx_tfBAZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>经典回顾：抗EGFR单抗在R/M SCCHN 的一线治疗探索</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/viNBwYJMsHkYxf87qaodRg</id>
    <link href="https://mp.weixin.qq.com/s/viNBwYJMsHkYxf87qaodRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO ASIA】束永前教授&amp;李相成教授团队研究获壁报展示，信迪利单抗联合安罗替尼用于晚期HCC一线治疗前景可期</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/DdQAJZ_CxY7EmJicf_vt5A</id>
    <link href="https://mp.weixin.qq.com/s/DdQAJZ_CxY7EmJicf_vt5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>